1) Impaired consciousness
2) Prostration
3) Multiple convulsions
4) Acidosis
5) Hypoglycemia
6) Severe malarial anemia (Hemoglobin <7 g/dL)
7) Renal Impairment
8) Jaundice
9) Pulmonary Edema
10) Significant bleeding
11) Shock
12) ( only) Hyperparasitemia >10%
Malaria is an important cause of stillbirth throughout endemic areas ( Figure 1 ). MIP contributes to 12–20% of stillbirths in endemic regions of sub-Saharan Africa, with lower rates if the mother undergoes treatment. 32 P. falciparum detection both in peripheral blood samples or placental samples at delivery nearly doubles the odds of stillbirth (odds ratio 1.81 and 1.5, respectively). 32 Stillbirth risk is higher in areas with low to intermediate endemicity compared to areas of high endemicity. 33 The risk of stillbirth can be modified with appropriate malaria intervention efforts. For example, the use of insecticide-treated bed nets (ITN) is associated with lower rates of placental malaria and stillbirth (risk ratio 0.67 [95% CI 0.45 to 1.00] for stillbirth). 34
IUGR = Intrauterine growth retardation. Reprinted with permission ( 4 ).
MIP increases the risk of low birth weight (LBW), and approximately 20% of cases of LBW in malaria-endemic areas are attributed to placental infection with malaria ( Figure 1 ). 35 A mother with a malaria-infected placenta is twice as likely to have a baby with LBW. 36 LBW in turn is associated with higher infant mortality rates. In Africa, LBW has been associated with a three - to 20-fold increase in the probability of infant mortality. 36 , 37 Parity is an important factor in LBW. Primigravidae with MIP have two to seven higher odds of LBW and mortality than multigravidae. 38 The timing of infection also seems to play a role in infant size. Second-trimester infection is more likely to result in LBW than third-trimester infection; but data on first-trimester infection are limited. 39
MIP causes LBW due to both intrauterine growth restriction (IUGR) and prematurity. Up to 70% of IUGR in endemic areas is due to malaria, presumably as a result of impaired oxygen and nutrient delivery to the fetus. 35 , 36 The contribution of malaria to preterm birth is also substantial, with up to 36% of prematurity in malaria-endemic areas attributable to Plasmodium infection. Prematurity may result from the host’s immune response to malaria parasites triggering early labor. 33 These adverse fetal effects are species specific, as P. ovale and P. malariae species are not associated with adverse birth outcomes.
Congenital malaria is defined as the identification of asexual P. falciparum parasites in the cord blood or peripheral blood of an infant during the first 7 days of life. 40 The true prevalence of congenital malaria is uncertain. While the prevalence was previously thought to be between <1% and 6%, 40 more recent studies have demonstrated a prevalence rate up to 33% in high-endemicity areas; but it is not clear how many of these congenital infections persist and cause clinical illness. 41 Most descriptive reports of congenital malaria are from infants who are born in non-endemic areas to mothers with a history of travel to endemic areas. Infant symptoms include fever associated with hepatosplenomegaly, hemolytic anemia, thrombocytopenia, and feeding intolerance. 41 These infants often become symptomatic between 10 and 30 days of life, although they can present later. Their symptoms may progress rapidly and can be fatal. 27 , 42 Because, much of the literature on congenital malaria is derived from case reports, more research is needed to better understand the epidemiology and pathophysiology of congenital malaria.
Offspring are affected by placental malaria into childhood, ( Figure 1 ). Prenatal malaria exposure is associated with an increased risk of early malaria infection in children as young as four to six months of age. 40 Placental parasitemia may increase the risk of malaria infections in infancy and childhood through several mechanisms. For example, MIP might interfere with maternal antibody passage to offspring, compromising the immunity of the fetus and newborn, making the offspring vulnerable to early malaria infections. 40 In utero exposure to malaria induces the development of T reg cells that lead to fetal immune tolerance to malaria antigens that persists into childhood. 43 Placental malaria has been associated with subsequent susceptibility to non-malaria infections, including measles and tetanus, suggesting additional effects on infant immunity that may be due to the obstruction of antibody passage across the placenta. 44 Acute placental malaria infection has been associated with increased one-year mortality in infants 45 and decreased length and weight gain in the first year of life. 46 , 47 MIP is also associated with anemia during infancy and the infant’s risk for anemia with maternal peripheral parasitemia at delivery is 11.8% and 9.2% with placental malaria infection. 48
The diagnosis of MIP can be challenging due to placental sequestration of parasitized erythrocytes, low circulating levels of parasites and limited resources in malaria endemic areas for advanced diagnostic techniques. Microscopic identification of malaria from the blood by an experienced and well-equipped technician remains the gold standard for malaria diagnosis. 49 However, rapid diagnostic tests (RDTs) that test for malaria antigens, like histidine-rich protein-1 (PfHRP2), are another option for malaria diagnosis. 49 – 51 RDTs are easier than microscopy to perform in low-resource settings, because they are not dependent on highly trained technicians in well-equipped laboratories. Therefore, RDTs might be the most appropriate point of care testing among symptomatic mothers in low-resource settings. 31 , 50 However, the use of RDTs might be insufficient in diagnosing MIP among mothers with asymptomatic infection, because RDTs require a higher circulating parasite burden than microscopy for detection. 52 RDTs are also insufficient to detect low amounts of circulating parasites because of placental sequestration. In research studies, the gold standard for malaria diagnosis has been placental histopathology, but it is not practical in many field sites. 53 , 54 Using microscopy of placental blood as the referent, the sensitivity of RDTs is 81% (95% CI 55–93) and the specificity is 94% (95% CI 76–99). 31 Molecular techniques, such as polymerase chain reaction (PCR) diagnosis, have increased sensitivity of diagnosis when compared to microscopy of placental blood to 94% (95% CI 86–98), but specificity of 94% (95% CI 86–98). 31 A new generation of ultrasensitive RDT’s is now being developed and might mitigate these diagnostic problems. 55
Prevention strategies in africa.
In malaria-endemic areas in Africa, a combination of vector control (preventing exposure to mosquitos) and chemoprevention (preventive medication-based treatment) strategies are used to prevent MIP. The World Health Organization (WHO) recommends a combined approach using insecticide treated bed nets (ITNs) to reduce exposure to mosquitoes carrying malaria and chemoprevention. 56 ITNs work by providing a physical barrier from mosquitoes, and repelling or killing susceptible mosquitoes, which reduces mosquito density and maintains the nets’ effectiveness even after the integrity of the barrier is compromised. 57 The use of ITNs in Africa have been shown to reduce LBW by 23%, miscarriages and stillbirths by 33%, and placental parasitemia by 23%. 58 Despite the proven efficacy of ITNs, uptake was estimated at only 39% in Africa between 2009 and 2011. 59 Since that time, ITN use has steadily increased, and an estimated 61% of pregnant women at risk for malaria slept under an ITN in 2017 56 , ( Figure 2 ). Malarial resistance to pyrethroids, the most commonly used insecticide in ITNs has been reported across sub-Saharan Africa and might impair future efficacy. 57
Percentage of the population in Sub-Saharan Africa at risk for malaria with access to ITN and using ITNs.
ITN: insecticide-treated bed nets Sources: World Health Organization and Malaria Atlas Project. Reprinted with permission ( 56 ).
Spraying the walls of households with insecticide to reduce human exposure to mosquitos, a procedure known as indoor residual spraying (IRS) is part of a comprehensive vector control program. Globally, IRS usage has declined and only 3% of the population at risk was protected by IRS in 2017, which might be related to a switch in insecticide from pyrethroids to more expensive chemicals. 56 IRS has been shown to improve outcomes of MIP, with women protected by IRS having lower incidence of MIP and lower risk of placental malaria. 60 , 61 When women were protected during greater than 90% of the time of their pregnancies, women had lower risk of preterm birth (risk ratio 0.35, 95% CI, 0.15–0.84). 60 IRS is an important part of a comprehensive vector control program and might contribute to improved birth outcomes in malaria-endemic regions.
Chemoprevention strategies have been successfully used to prevent adverse health outcomes associated with MIP. The most efficacious of these strategies uses a technique of intermittent preventive treatment in pregnancy (IPTp). IPTp consists of providing monthly doses of anti-malarial medication to all pregnant women starting in the second trimester. Women who receive at least 2 courses of IPTp have a relative risk reduction of 40% for moderate to severe anemia, 61% for antenatal parasitemia, 55% for placental parasitemia and 27% for low birthweight. 62 Since 2012, the WHO has recommended monthly IPTp to reduce the incidence of these complications of pregnancy. 63 However, despite WHO recommendations, in 2017, only 22% of pregnant women received three or more doses of IPTp in Sub-Saharan Africa ( Figure 3 ). 64
Percentage of pregnant women receiving IPTp, by dose in Sub-Saharan Africa, 2010–2017.
ANC: antenatal care, IPTp: intermittent preventive treatment in pregnancy, listed by dose. Sources: National Malaria Programme, World Health Organization, US Centers for Disease Control and Prevention. Reprinted with permission ( 56 ).
Sulfadoxine-pyrimethamine (SP) has been the drug of choice for IPTp in women who are HIV-negative. 65 Plasmodium resistance to SP has emerged through multiple mutations in the P. falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate synthetase (Pfdhps), with penetrance of this haplotype in some areas of greater than 90%. 66 Due to increasingly more resistant organisms, IPTp with SP is less effective at inhibiting parasite growth and preventing fetal growth restriction. 66 In light of increasing resistance, alternative strategies for chemoprevention are being tested, including IPTp with alternative medications and strategies of intermittent screening and treatment in pregnancy (ISTp). ISTp strategies use RDTs to diagnosis MIP at multiple time points and treat only when RDTs are positive. However, these strategies depend on accurate diagnosis of MIP and have not been proven to be effective alternatives to IPTp-SP even in highly resistant areas. 66 IPTp with dihydroartemisinin-piperaquine (DP) might be a promising alternative to IPTp-SP, but more research is needed in this area. 66
In South America and Asia, where malaria transmission is typically lower than in Africa, data on traditional chemoprophylaxis is limited. Prophylaxis with mefloquine or chloroquine has been efficacious for preventing MIP in pregnant women in Thailand. 67 , 68 Other chemoprophylactic strategies employed outside of Africa have included monthly IPTp-SP with azithromycin and ISTp-SP and artesunate. These strategies show promise in the reduction of low birth weight or maternal parasitemia.
All MIP infections should be treated promptly to avoid complications to the mother and fetus. 31 To ensure safety of treatment in pregnancy, the WHO recommends trimester-specific and species-specific treatment strategies for uncomplicated malaria ( Table 1 ). For first trimester treatment of P. falciparum , the WHO recommends a 7-day treatment course of quinine with clindamycin, and second line treatment includes artemisinin-based combination therapy (ACT) or oral artesunate with clindamycin. 65 First trimester treatment of uncomplicated non- falciparum malaria consists of chloroquine or quinine for chloroquine-resistant infections.
Second and third trimester treatment of uncomplicated malaria follows the same guidelines as treatment for malaria in non-pregnant adults. 31 Therefore, first line treatments with ACTs can be used in MIP. ACTs include a short-acting artemisinin component and a longer acting partner drug, such as SP. 69 The potent artemisinin reduces the number of parasites quickly and the longer acting partner drug acts on the remaining parasites and provides a post-treatment prophylactic effect, preventing new infections. 69 ACTs have achieved cure rates as high as 99.2% for uncomplicated MIP without demonstrating significant safety concerns. 70
Severe malaria has historically been attributed to infections with P. falciparum , but more recent evidence has included P. vivax as a significant contributor to severe malaria. 30 For pregnant patients with severe malaria, the WHO recommends the same treatments for both P. falciparum and P. vivax infections. The WHO also recommends treatment with primaquine after delivery to achieve cure and prevent relapses by eradicating P. vivax sequestered in the liver, ( Table 1 ). 30
Artemisinins are the most efficacious drugs for severe MIP after the first trimester. Because they are embryotoxic and teratogenic in animal studies, the WHO does not recommend their use in the first trimester for uncomplicated malaria. However, their use is recommended even in the first trimester in cases of severe malaria because of the high risk of maternal mortality. 30 Data on the use of artemisinins in the first trimester in humans show no associated increased risk of adverse pregnancy outcomes. 30 Long-term neurodevelopmental studies are needed to evaluate the safety of different drug combinations on child development.
Quinine is an alternative to artemisinin that has been used for centuries for the treatment of malaria. Although it is not considered embryotoxic or teratogenic in animal studies, it is less well-tolerated in humans. 30 Quinine can prolong the cardiac QT interval and is associated with tinnitus, headache, blurred vision, altered auditory acuity, nausea, diarrhea, and, rarely, massive hemolysis. 65 These side effects reduce compliance with treatment regimens and lead to higher levels of treatment failure. 30
An efficacious vaccine against malaria could be of particular benefit for pregnant women. One vaccine, RTS,S, is now approved by the European Medicines Agency, but is only modestly effective. 71 Efforts are also underway to develop a vaccine targeting the VAR2CSA antigen to protect women against pregnancy-associated malaria. 72
Co-infections with malaria and HIV worsen morbidity and mortality for each disease, possibly due to alterations in the balance between the immune response to malaria and stimulation of viral replication. 73 MIP is associated with a two-fold higher HIV viral load. Conversely, women living with HIV experience more placental and peripheral malaria, higher parasite densities, more frequent febrile illnesses, more severe anemia and worse birth outcomes compared to non-HIV infected mothers with MIP. 73 Chemoprevention for women living with HIV in malaria-endemic areas includes daily co-trimoxazole. SP is discouraged for chemoprevention due to potential adverse drug reactions between SP and co-trimoxazole. 74 Although pregnant women living with HIV have the greatest risk of severe MIP, treatment strategies for severe malaria in conjunction with HIV treatments have not been well studied. 30 , 73 The WHO recommends against the use of zidovidine or efavirenz and the use of artesunate amodiaquine due to neutropenia and hepatotoxicity respectively. 65 Pregnant women receiving highly active antiretroviral therapy regimens should receive quinine when cardiac monitoring is available.
Malaria is among the most common and easily preventable causes of poor birth outcomes in the world. IPTp and ITNs distribution programs have helped decrease malaria risk among pregnant women in many parts of the world. However, greater efforts are needed especially in light of increasing drug and insecticide resistance. A better understanding of the pathogenesis of malaria during pregnancy could lead to the development of new interventions to prevent its health consequences.
DISCLOSURES
The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.
IMAGES
COMMENTS
Malaria is a severe disease caused by parasites of the genus Plasmodium, which is transmitted to humans by a bite of an infected female mosquito of the species Anopheles. Malaria remains the leading cause of mortality around the world, and early diagnosis and fast-acting treatment prevent unwanted outcomes.
This documentary video discusses the epidemiology of malaria; strategies for prevention, including vector control and vaccines; and the pipeline of promising new drugs for the fight to eliminate ma...
Methods A systematic literature review was undertaken across four medical and life sciences databases (PubMed, Cochrane Central, Embase, and Web of Science) from their inception to July 2016 to compare the effectiveness of different preventive measures on malaria incidence.
Public health strategies for malaria in endemic countries aim to prevent transmission of the disease and control the vector. This historical analysis considers the strategies for vector control developed during the first four decades of the twentieth century. In 1925, policies and technological advances were debated internationally for the first time after the outbreak of malaria in Europe ...
In order to assess the disparities between efficacy and effectiveness of malaria control interventions, and the range of PE observed on the field, we conducted a systematic review of the literature on epidemiological studies providing data about the protective effectiveness of control interventions for malaria prevention (CIMP) under field ...
The aim of this systematic review was to collate and summarize the impact of integrated malaria prevention in low- and middle-income countries on malaria burden. Literature on integrated malaria prevention, defined as the use of two or more malaria prevention methods holistically, was searched from 1st January 2001 to 31st July 2021.
This Review discusses the epidemiology, prevention, and treatment of malaria in the US.
Background Global interest in malaria elimination has prompted research on active test and treat (TaT) strategies. Methods A systematic review and meta-analysis were conducted to assess the effectiveness of TaT strategies to reduce malaria transmission. Results A total of 72 empirical research and 24 modelling studies were identified, mainly focused on proactive mass TaT (MTaT) and reactive ...
Purpose of Review Malaria is a prevalent disease in travelers to and residents of malaria-endemic regions. Health care workers in both endemic and non-endemic settings should be familiar with the latest evidence for the diagnosis, management and prevention of malaria. This article will discuss the recent malaria epidemiologic and medical literature to review the progress, challenges, and ...
Abstract Purpose of review: Malaria is a prevalent disease in travelers to and residents of malaria-endemic regions. Health care workers in both endemic and non-endemic settings should be familiar with the latest evidence for the diagnosis, management and prevention of malaria. This article will discuss the recent malaria epidemiologic and medical literature to review the progress, challenges ...
Malaria is a major public health problem in developing countries. The burden of malaria in fragile and conflict-affected states (FCAS) is increasing year by year. Moreover, the population living in FCAS is often the most vulnerable and at high risk of malaria due to factors, such as deteriorating healthcare system, mass relocations, and reduced resilience to shocks. Therefore, this scoping ...
Integrated malaria prevention advocates the use of several malaria prevention measures holistically at households and in the community. The aim of this systematic review was to collate and summarize the impact of integrated malaria prevention in low- and middle-income countries on malaria burden. Methods: Literature on integrated malaria ...
To the best of our knowledge, this is the first systematic literature review on the effectiveness and the cost-effectiveness of MSAT, and the second attempt to revisit this intervention since the WHO Malaria Policy Advisory Committee (MPAC) issued a recommendation on its use in 2015. 5 In the absence of sufficient evidence, the WHO MPAC ...
Better understanding of the complex interactions between malaria and malnutrition is crucial for optimally targeting interventions where both conditions co-exist. This systematic review aimed to assess the evidence of the interplay between malaria and malnutrition.
Malaria is known to cause around 1 million deaths per annum. This life-threatening disease is mostly prevalent in Africa. Due to the burgeoning proble…
A systematized literature review which involved a structured search of the malaria technological innovations followed by a quantitative and narrative description and synthesis of the innovations was carried out.
Prevention: Prevention of malaria involves controlling mosquito vectors through use of insecticide-treated nets, use of antimalarial drugs for prophylaxis, administration of vaccines (such as RTS, S vaccine), and use of mosquito bite prevention measures such as anti-mosquito lotions and repellents.
Malaria is caused by the four species of the protozoa of the genus Plasmodium, which is transmitted by the bite of the female Anopheline mosquito, congenitally, or through exposure to infected blood products. This article reviews the epidemiology, pathology, clinical symptoms, diagnosis, and treatment of malaria in pregnant women.
Malaria is an endemic in various tropical countries. The gold standard for disease detection is to examine the blood smears of patients by an expert medical professional to detect malaria parasite called Plasmodium. In the rural areas of underdeveloped countries, with limited infrastructure, a scarcity of healthcare professionals, an absence of sufficient computing devices, and a lack of ...
The 2021 CDC STI Treatment Guidelines included a systematic review of the available literature on STI PEP and concluded that further studies were necessary to determine whether it would be an effective strategy for bacterial STI prevention (5).
Background: Biologic graft infection (BGI) is one of the main complications in graft reconstructions. However, very little evidence exists regarding the epidemiology of BGI, as most of the data come from sparse reports. Moreover, most of the series did not detail the treatment and outcome of graft infections. The aim of this systematic review of the literature is to provide a comprehensive ...
This systematic review aims to provide a summary and overview of literature discussing factors influencing uptake of these two malaria control strategies in Southeast Asian countries.
A case of Powassan encephalitis occurred in Manitoba, Canada, after the bite of a black-legged tick. Awareness of this emerging tickborne illness is needed because the number of vector tick species is growing. No specific treatment options exist, and cases with illness and death are high. Prevention is crucial.
These discrepancies in implementation of good practices towards malaria prevention and control might be due to differences in sociodemographic characteristics (gender, age, educational, and income levels), the community's awareness about malaria, and their attitudes towards malaria prevention and control.
Malaria; Melanoma; Multiple sclerosis ... "We hope our work can contribute to safer and more effective treatment of rheumatic diseases ... Systematic literature review provides evidence base for ...
Pregnant women in all trimesters with parasitologically confirmed uncomplicated falciparum malaria were included irrespective of symptoms. This review attempted to re-calculate proportions of treatment success applying the same definition as the standard WHO methodology for non-pregnant populations.
s. rept. 118-207 - departments of labor, health and human services, and education, and related agencies appropriation bill, 2025 118th congress (2023-2024)
The most widely used measures of declining burden of malaria across sub-Saharan Africa are predictions from geospatial models. These models apply spatiotemporal autocorrelations and covariates to parasite prevalence data and then use a function of parasite ...
A Multidisciplinary Update on Treatment Modalities for Metastatic Spinal Tumors with a Surgical Emphasis: A Literature Review and Evaluation of the Role of Artificial Intelligence. Cancers 2024 , 16 , 2800.
Malaria in pregnancy is associated with anemia, stillbirth, low birth weight and maternal and fetal death. We review the challenges to diagnosing malaria in pregnancy, as well as strategies to prevent and treat malaria in pregnancy. Finally, we discuss the current gaps in knowledge and potential areas for continued research. Go to: